Literature DB >> 8578185

Non-bleeding visible vessel treatment: perendoscopic injection therapy versus omeprazole infusion.

C Grosso1, A Rossi, P Gambitta, M Bini, G Zanasi, Z Pirone, R Arcidiacono.   

Abstract

BACKGROUND: The non-bleeding visible vessel in a peptic ulcer is the highest risk factor for a bleeding recurrence among not actively bleeding lesions. Perendoscopic injection of sclerosing compounds is usually used as prophylaxis against rebleeding.
METHODS: Forty-two patients with visible vessels in a peptic ulcer at an emergency endoscopic procedure have been studied: 21 patients underwent prophylactic perendoscopic hemostasis, and 21 patients were infused with omeprazole intravenously.
RESULTS: Eight patients (19%), four in each group, had early rebleedings (within 48 h after the enrollment). There was no significant difference between the two types of treatment. At the endoscopic control after 48 h there were significantly more lesions with higher risk of rebleeding (Forrest IIa and IIb) in the group treated with perendoscopic hemostasis.
CONCLUSIONS: Our data suggest that omeprazole infusion is a valid alternative to injection treatment of non-bleeding visible vessels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578185     DOI: 10.3109/00365529509101593

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  A head to head comparison of oral vs intravenous omeprazole for patients with bleeding peptic ulcers with a clean base, flat spots and adherent clots.

Authors:  Serif Yilmaz; Kadim Bayan; Yekta Tüzün; Mehmet Dursun; Fikri Canoruç
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

Review 2.  Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer.

Authors:  Venodhar R Julapalli; David Y Graham
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

3.  Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.

Authors:  J Labenz; U Peitz; C Leusing; B Tillenburg; A L Blum; G Börsch
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

4.  Oral proton pump inhibitors are as effective as endoscopic treatment for bleeding peptic ulcer: a prospective, randomized, controlled trial.

Authors:  Jin Ii Kim; Dae Young Cheung; Se Hyun Cho; Soo-Heon Park; Joon-Yeol Han; Jae Kwang Kim; Sok Won Han; Kyu Yong Choi; In Sik Chung
Journal:  Dig Dis Sci       Date:  2007-05-19       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.